Alterity Therapeutics
ATHE
14 hedge funds and large institutions have $808K invested in Alterity Therapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 13 → 14 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
37% less capital invested
Capital invested by funds: $1.29M → $808K (-$477K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$22.4K |
| 2 |
VF
Virtu Financial
New York
|
+$15.8K |
| 3 |
PCA
Providence Capital Advisors
Charlotte,
North Carolina
|
+$2.78K |
| 4 |
OIA
Optimum Investment Advisors
Chicago,
Illinois
|
+$1.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$309K |
| 2 |
Morgan Stanley
New York
|
-$82.5K |
| 3 |
Millennium Management
New York
|
-$48K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36.5K |
| 5 |
HF
HRT Financial
New York
|
-$24.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $723K | -$82.5K | -5,930 | -9% |
|
|
TSS
2
Two Sigma Securities
New York
| $20K | +$22.4K | +1,611 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $15K | -$36.5K | -2,622 | -69% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $15K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $14K | +$15.8K | +1,135 | New |
|
|
HF
6
HRT Financial
New York
| $13K | -$24.2K | -1,738 | -62% |
|
7
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
|
PCA
8
Providence Capital Advisors
Charlotte,
North Carolina
| $3K | +$2.78K | +200 | New |
|
|
GWM
9
Geneos Wealth Management
Englewood,
Colorado
| $1K | – | – | – |
|
|
OIA
10
Optimum Investment Advisors
Chicago,
Illinois
| $1K | +$1.29K | +93 | New |
|
|
APA
11
American Portfolios Advisors
Holbrook,
New York
| $105 | – | – | – |
|
|
12
Renaissance Technologies
New York
| – | -$309K | -23,790 | Closed |
|
|
13
Millennium Management
New York
| – | -$48K | -3,694 | Closed |
|
14
UBS Group
Zurich,
Switzerland
| – | -$6K | -466 | Closed |
|
ATHE Hedge Fund Activity: Q3 2021 in Review
14 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2021, worth a combined $808K — down 37% from $1.29M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATHE positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $22.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $309K sold.
- 14 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2021, up from 13 in Q2 2021.
- Funds reported $808K of Alterity Therapeutics stock for Q3 2021, down 37% quarter-over-quarter.
- 4 funds opened new Alterity Therapeutics positions in Q3 2021 and 3 closed out, a net change of +1 holder.
- The largest Alterity Therapeutics buyer in Q3 2021 was Two Sigma Securities, an estimated $22.4K added.
- The largest Alterity Therapeutics seller in Q3 2021 was Renaissance Technologies, an estimated $309K sold.
Based on aggregated 13F filings for Q3 2021.